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Environment Changes Genetic 
Effects on Respiratory Conditions 
and Allergic Phenotypes
Yong Song1,2, Michelle J. Schwager3, Vibeke Backer4, Jing Guo1,2, Celeste Porsbjerg4, Siew-
Kim Khoo3,5, Ingrid A. Laing3, Eric K. Moses2, Peter LeSouëf3 & Guicheng (Brad) Zhang1,2,3
The prevalence of asthma and allergic diseases is disproportionately distributed among different 
populations, with an increasing trend observed in Western countries. Here we investigated how 
the environment affected genotype-phenotype association in a genetically homogeneous, but 
geographically separated population. We evaluated 18 single nucleotide polymorphisms (SNPs) 
corresponding to 8 genes (ADAM33, ALOX5, LT-α, LTC4S, NOS1, ORMDL3, TBXA2R and TNF-α), the 
lung function and five respiratory/allergic conditions (ever asthma, bronchitis, rhinitis, dermatitis and 
atopy) in two populations of Inuit residing either in the westernized environment of Denmark or in the 
rural area of Greenland. Our results showed that lung function was associated with genetic variants 
in ORMDL3, with polymorphisms having a significant interaction with place of residence. LT-α SNP 
rs909253 and rs1041981 were significantly associated with bronchitis risk. LT-α SNP rs2844484 was 
related to dermatitis susceptibility and was significantly influenced by the place of residence. The 
observed gene-phenotype relationships were exclusively present in one population and absent in the 
other population. We conclude that the genotype-phenotype associations relating to bronchitis and 
allergy susceptibility are dependent on the environment and that environmental factors/lifestyles 
modify genetic predisposition and change the genetic effects on diseases.
The global prevalence of asthma and other allergic conditions such as rhinitis, dermatitis and atopy, have been 
increasing for the past 30 to 40 years1–3. This rising trend is attributed to regions that are becoming more urban-
ised and ‘Westernised’4. The risk factors contributing to allergen hypersensitivity originate from an individual’s 
genetics, its accompanying lifestyles and the surrounding environment. To date, genetic association studies suf-
fer from inconsistencies in identifying the susceptibility genes for asthma and allergy5. The genes/loci that are 
identified to be associated with the disease vary in different ethnic populations and in people from different 
geographic regions5. Thus, gene-environment interactions are likely to be critical determinants of asthma and 
allergy susceptibility.
The Inuit present a unique population to investigate the complex gene and environment interaction as they 
are homogenous and genetically distinct from other ethnicities6. This population descends from generations 
living in the harsh Artic environment. Their acculturation to the modern world, including migrating to Western 
countries, has brought a change in allergic condition prevalence in Inuit7. For the present study, we recruited two 
Inuit populations both born in Greenland but the first resided in their native country while the second migrated 
to the Western European country of Denmark. The comparison of the immigrants with Greenlandic Inuit is an 
ideal way to investigate how environmental factors affect genetic effects on disease susceptibility. The two Inuit 
populations were unselected for respiratory/allergic conditions, adjusted for several confounders particularly 
genetic admixture, and representative of the general Inuit population in each residing environment so that the 
findings resulting from this study can be generalised.
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We selected 8 candidate genes which are related to asthma/allergic conditions or pulmonary function 
based on literature reports8–14. From these 8 genes, the genetic effects of 19 prospective single nucleotide pol-
ymorphisms (SNPs) on the lung function and five respiratory/allergic conditions (ever asthma, bronchitis, 
rhinitis, dermatitis and atopy) were compared in the two populations of Inuit. The interaction with place of 
residence was further investigated in the association studies. We hypothesised that the selected genetic variants 
were significantly associated with respiratory conditions or allergic prevalence in Inuit, and that the genetic 
effects were influenced by the residing environment or life styles. As differences of smoking condition and 
ancestral ethnicity were identified between the two populations in the current study, we also investigated the 
genotype-phenotype association profile, taking into account smoking effects and using the Inuit population 
with full ethnicity.
Results
Demographics. The demographic data for the two study populations are shown in Table 1. A lower pro-
portion of Danish male Inuit (27.4%) compared to Greenlandic male Inuit (46.7%) was recruited in this study 
(P < 0.001). The proportion of smokers in the Greenlandic Inuit (88.1%) was higher than that in the Danish Inuit 
(78.8%, P < 0.001). In regards to the lung function, Greenlandic Inuit had lower values of FEV1 and FVC than 
Danish Inuit in both male and female populations (P < 0.05). After adjustment of gender, age, height, ethnicity 
and smoking status, this difference remained significant in the female population.
Inuit residing in Denmark had a higher prevalence of rhinitis (60.0% vs 42.7%, P < 0.001), but a lower prev-
alence of bronchitis (13.9% vs 25.6%, P < 0.001) and dermatitis (36.3% vs 57.7%, P < 0.001) compared with 
Greenlandic Inuit. These differences remained significant after adjustment for gender, age, height, ethnicity and 
smoking status. There was no significant difference between the two Inuit groups of ever asthma and atopy prev-
alence. Additionally these diseases were related to one another, as demonstrated by the interrelationship diagram 
in Fig. 1. We studied the relevance of different phenotypes by pooling the two Inuit populations together and 
adjusting for gender, age, height, ethnicity and place of residence and observed a positive correlation between 
smoking status and bronchitis prevalence and a negative correlation between lung function parameters (FEV1 
and FVC) and bronchitis prevalence (P < 0.01).
Genotype frequencies. We did not observe any deviation from the Hardy-Weinberg Equilibrium for all 
SNP genotype frequencies in both populations (P > 0.05; Supplementary Table S1). Apparent differences in gen-
otype frequencies between the two Inuit populations (P < 0.05) were observed in ADAM33 rs528557, the three 
ALOX5 SNPs, LT-α rs2844484, TBXA2R rs4523, TNF-α rs1799964 and rs1800629. In the pure Inuit population 
(both grandparents and parents are Inuit), only significant differences were found for ALOX5 SNPs (rs892690 and 
rs2115819), TBXA2R rs4523 and TNF-α rs1799964.
Lung function parameters and SNPs. The lung function data for the 18 SNP genotypes are shown in the 
Supplementary Table S2. After adjusting for gender, age, height, ethnicity and smoking status, ORMDL3 SNPs 
(rs12603332 and rs4065275) were significantly associated with lung function (FEV1 and FVC) in Greenlandic 
Inuit whereas ADAM33 rs2787094 was found to associate with FEV1 in Danish Inuit (P = 0.045). When we fur-
ther tested these associations using the sensitivity analysis, the association of polymorphisms with lung function 
Greenland 
(n = 615)
Denmark 
(n = 643) P value
Gender (male) 46.7 (287) 27.4 (176) <0.001
Age (yr) 42.4 ± 14.78 43.4 ± 12.40 0.209
Height (cm) 163.1 ± 9.48 163.1 ± 10.10 0.995
Ethnicity#
 Full Inuit 91.5 (558) 53.2 (337)
 Non-full Inuit 8.5 (52) 46.8 (297) <0.001
Smoker 88.1 (542) 78.8 (507) <0.001
Lung Function
 FEV1 (L)
Male 3.7 ± 0.95 3.9 ± 0.89 0.017
Female 2.7 ± 0.71 2.8 ± 0.64 0.016
 FVC (L)
Male 4.7 ± 1.13 4.9 ± 1.04 0.041
Female 3.3 ± 0.79 3.4 ± 0.72 0.014
Allergic/respiratory conditions
 Ever asthma 8.5 (52) 9.2 (59) 0.646
 Bronchitis 25.6 (157) 13.9 (89) <0.001
 Rhinitis 42.7 (173) 60.0 (386) <0.001
 Dermatitis 57.7 (355) 36.3 (233) <0.001
 Atopy 24.0 (30) 23.4 (121) 0.896
Table 1. Demographic and phenotypic data for Inuit residing in Greenland and Denmark. Data are presented 
as Mean ± SD or % (n); #Full Inuit means that all 4 grandparents are Inuit; Non-full Inuit means at least 1 non-
Inuit grandparent.
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remained significant for ORMDL3 SNPs (P < 0.05, Supplementary Table S8A), but not for ADAM33 rs2787094 
(P = 0.473, Supplementary Table S8B). The homozygous CC genotype of rs12603332 and the GG genotype of 
rs4065275 in ORMDL3 were associated with higher values of FEV1 and FVC than the homozygous CT and GA 
genotypes in Greenlandic Inuit respectively (Fig. 2). Moreover, the interaction of the ORMDL3 SNPs (rs12603332 
and rs4065275) with place of residence were statistically significant for the lung function (FEV1 and FVC) 
(P < 0.05, Supplementary Table S9). Apart from these, we did not observe significant associations of any other 
SNPs with lung function in either the whole population or the full Inuit population.
Ever asthma and SNPs. No significant difference in the prevalence of ever asthma was found for genotypes 
of the examined SNPs (Supplementary Table S3). However, in the sensitivity analysis, Greenlander with homozy-
gous AA genotype of ALOX5 SNP rs892690 had a significantly increased risk of ever asthma compared to GG 
genotype (P < 0.05, Supplementary Table S8A).
Bronchitis and SNPs. Significant differences in the prevalence and risk of bronchitis were found in gen-
otypes of LT-α and TNF-α, but not in ALOX5, LTC4S, TBXA2R, ADAM33, NOS1 and ORMDL3 in the Inuit 
populations residing both in Greenland and in Denmark (Supplementary Table S4). LT-α SNP rs2844484 was 
significantly associated with bronchitis, but only within the Danish population. On the other hand, two TNF-α 
SNPs (rs1800630 and rs1800629) were exclusively associated with bronchitis within the Greenlandic population. 
Using the sensitivity analysis, we further revealed the significant associations of LT-α rs909253 and rs1041981 
with bronchitis in Danish Inuit, while the association of TNF-α rs1800630 with bronchitis did not remain signif-
icant (Supplementary Table S8).
The sensitivity analysis showed that in Danish Inuit, the prevalence of bronchitis was significantly lower 
among heterozygous CT for LT-α rs2844484 (8.8%) than among homozygous CC (19.4%) and TT (22.2%). 
Danish Inuit with genotype CC for LT-α rs909253 (Fig. 3a) and AA for and rs1041981 (Fig. 3b) had a significantly 
increased prevalence of bronchitis, compared to other genotypes. In Greenland, the Inuit with genotype GA of 
TNF-α rs1800629 had a significantly higher prevalence of bronchitis (38.9%) than that in GG (25.4%). However, 
interactions of the SNPs with place of residence were not statistically significant in the prevalence of bronchitis 
(Supplementary Table S9).
Rhinitis and SNPs. No significant associations were found between rhinitis and any SNPs for Inuit residing 
in either Greenland or Denmark (Supplementary Table S5). Furthermore, the sensitivity analysis did not reveal 
any significant associations in the two populations (Supplementary Table S8).
Dermatitis and SNPs. As shown in Supplemental Table 6, within the Greenlandic population, Inuit with 
LT-α rs2844484 homozygous CC (54.5%) had a significantly lower prevalence of dermatitis compared with 
Inuit with CT genotype (P = 0.035). The same significant relationship (P = 0.025, Fig. 3c and Supplementary 
Table S8A) was detected within the Greenlandic group using the sensitivity analysis. The place of residence var-
iable was significantly interacted with LT-α rs2844484 on dermatitis (P = 0.009, Supplementary Table S9). No 
significant differences in the prevalence and risk of dermatitis and interaction with place of residence were found 
in other SNPs examined within the two Inuit populations.
Atopy and SNPs. Significant differences in the prevalence and risk of atopy and association with atopy were 
only found in genotypes of ALOX5 and LTC4S (Supplementary Table S7). However, these differences did not 
persist after the sensitivity analysis (Supplementary Table S8). There were no significant interactions for place of 
residence association with the SNPs on atopy (Supplementary Table S9).
Figure 1. Interrelations of the respiratory/allergic diseases: Venn diagram shows the interrelations of the 
respiratory/allergic diseases in the two populations.
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Correction for multiple tests. As shown in Table 2, the identified associations were further adjusted for 
multiple tests. The effects of ALOX5 rs892690 on ever asthma, LT-α rs2844484 and TNF-α rs1800629 on bron-
chitis were not considered significant with the adjusted thresholds, while the others remained significant after the 
correction.
Genotype and gene expression associations. Associations between genotype of the selected SNPs 
(ORMDL3 rs12603332 and rs4065275, LT-α rs909253, rs1041981 and rs2844484) and blood-specific gene 
expression levels were analysed using GTEx portal. We revealed that ORMDL3 gene expression was up-regulated 
in blood cells of people with allele T of rs12603332 (P = 1.1e-25) or allele A of rs4065275 (P = 1.6e-25). The 
polymorphisms of LT-α rs909253 and rs1041981 were not significantly related to mRNA expression of 
LT-α (P > 0.05). Compared to CC, genotype CT of rs2844484 was related to a higher LT-α gene expression 
(P = 0.0065).
Discussion
In this study, we compared the genetic effects of 18 single nucleotide polymorphisms in 8 asthma and allergic 
candidate genes on the lung function and respiratory/allergic conditions in two populations of Inuit: one born 
and residing in Greenland and the other first generation Inuit immigrants of Denmark. We discovered several 
significant associations with respiratory/allergic conditions in the eight candidate genes after adjusting for the 
confounding factors (e.g. gender, age, height, ethnicity and smoking), using the sensitivity analysis and correcting 
for multiple testing. These include 1) Lung function parameters are associated with genetic variants in ORMDL3, 
with polymorphisms having a significant interaction with place of residence; 2) Frequency of bronchitis is asso-
ciated with variants in the LT-α gene; 3) Dermatitis risk is related to the genotype distribution of LT-α SNP 
Figure 2. Associations of lung function and genotypes in the sensitivity analysis: Lung function (FEV1 and 
FVC) values in Greenlandic and Danish Inuit with full ethnicity were stratified by the genotypes of ORMDL3 
SNPs rs12603332 (a and b) and rs4065275 (c and d). P values were adjusted for age, gender, height, and 
smoking. Box and whisker plots represent median with 10th and 90th centiles.
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rs2844484, with a significant interaction with place of residence. The gene-phenotype relationship was exclusively 
observed in one population and not the other, indicating that environment plays a vital role of regulating the 
genetic effects.
Comparison of the pulmonary function in the two populations indicated that Denmark Inuit had higher lung 
function FEV1 and FVC values than Greenlandic Inuit. However, after correcting for the confounding variables 
(e.g. gender, age, height, ethnicity and smoking status) in the analysis, we found that only female Inuit in Denmark 
had a better lung function performance than the corresponding population in Greenland. In analysing the res-
piratory conditions and allergic phenotypes, we did not observe a significant difference of prevalence in asthma, 
but a higher prevalence of rhinitis and a lower prevalence of bronchitis (13.9%) and dermatitis (36.3%) in Danish 
Inuit compared with Greenlandic Inuit. The high prevalence of bronchitis and dermatitis in Greenlandic Inuit 
observed in this study is consistent with the reported frequency of these diseases in Greenlander7. Indigenous 
Inuit were previously reported to have reduced respiratory health due to high tobacco consumption7. In the 
present study, we also noted that the proportion of smokers was higher in Greenlandic Inuit compared to Danish 
Inuit. A positive association between bronchitis and smoking status and a negative association between bronchitis 
frequency and lung function were revealed when investigating two populations as a whole. Thus, we conclude 
that smoking tobacco is a risk factor for bronchitis, and the development of bronchitis is likely to contribute to the 
compromised lung function of Inuit.
Out of the 18 SNPs that we examined, ORMDL3 variants (rs12603332 and rs4065275) were significantly associ-
ated with lung function in Greenlandic Inuit after controlling the confounding variables and showed an interaction 
with place of residence. ORMDL3 is involved in endoplasmic reticulum–mediated Ca2+ homeostasis and unfolded 
protein response which potentially activate inflammatory processes and T-lymphocyte induction15. We found that 
the T allele of rs12603332 and the A allele of rs4065275 had a reduced lung function compared to the C or G allele, 
Figure 3. Prevalence of bronchitis/dermatitis and genotypes in the sensitivity analysis: Prevalence rates (%) 
of bronchitis in Greenlandic and Danish Inuit with full ethnicity were stratified by the genotypes of LT-α 
SNP rs909253 (a) and rs1041981 (b), while dermatitis prevalence was stratified by the genotypes of LT-α SNP 
rs2844484 (c). P values were adjusted for age, gender, height, and smoking.
www.nature.com/scientificreports/
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respectively. A change from C to T allele in rs12603332 was reported to result in an increase in ORMDL3 transcrip-
tion16. Indeed, according to the GTEx database17, ORMDL3 rs12603332 and rs4065275 are expression quantitative 
trait loci (eQTL). Allele T of rs12603332 or allele A of rs4065275 was correlated to overexpression of ORMDL3 
gene. Thus, increased ORMDL3 may provoke an inflammatory response in lung tissue and affect pulmonary per-
formance. It should be noted that ORMDL3 is well known as an asthma susceptibility gene as confirmed in genetic 
association studies in several ethnic populations16 and also associated with smoking exposure18. Further testing on 
how smoking and other environmental factors regulate the effect of ORMDL3 SNPs on lung function is of interest, 
particularly in light of the uncertainty surrounding ORMDL3’s direct relation to asthma pathogenesis.
We also found that Danish Inuit with the minor allele homozygous genotypes CC and AA for rs909253 and 
rs1041981 in LT-α, respectively, had 2-fold increased risk of developing bronchitis. LT-α rs909253 is located in the 
first intron of the gene while LT-α rs1041981 is located in the chromosomal region that transcribes for codon 60 
and translates into an amino acid change, from threonine to asparagine. The C allele of rs909253 was reportedly 
associated with increased synthesis of LT-α19. However, GTEx analysis did not support that the polymorphisms of 
both variants were significantly related to functional expression of LT-α. Interestingly, these SNPs were confirmed 
to be in high linkage disequilibrium by a genome wide association study on lung function20 and the current study 
(Supplementary Fig. 1). Individuals with a haplotype consisting of CC genotype of rs909253 and AA genotype of 
rs1041981 produced substantially higher amounts of LT-α in their peripheral blood mononuclear cells21. Thus, 
the individual SNPs may have minimal functional impact and it is likely that LT-α rs909253 and rs1041981 affect 
the functional expression in linkage disequilibrium forming a functional haplotype. Functionally, LT-α is a major 
player of the lymphotoxin signalling pathway in regulating the development and maintenance of secondary lym-
phoid organs and controlling organ design22. Previously it was reported that rs909253 was associated with pul-
monary function in a cohort of Caucasian smokers23. Since the inflammation response to external environmental 
factors involves this cytokine, the bronchitis associations found in Inuit further support that LT-α play a biolog-
ical or pathological role in the development of bronchitis in the Inuit population. In addition, the two genetic 
variants in LT-α were only associated with bronchitis in Danish Inuit, but not in Greenlandic Inuit. These find-
ings indicate that the environmental factors interact with different genetic variants and alter the genetic effects 
on bronchitis. However, living place was not significantly interacted with the genotype–phenotype associations. 
Other important factors were proposed in the development of respiratory illness in Greenlandic Inuit, including 
indoor chimney heating, dry frost at low temperatures, passive smoke exposure during infancy, respiratory infec-
tions during childhood etc7. Studies are needed to explore whether these environmental factors are responsible 
for mediating genetic predisposition of LT-α to bronchitis.
A genetic variant (rs2844484) in the LT-α gene was also revealed to associate with dermatitis. LT-α rs2844484 
is positioned upstream from the start of LT-α and this SNP is part of a region identified as a hypersensitive site 
shown to contain upstream stimulatory factors24. This family of transcription factors has the capability to vary LT-α 
expression when under stress and immune-related conditions24. It is also suggested that LT-α plays a crucial role 
in the inflammation mechanism associated with immune responses to infectious agents, by stimulating chemok-
ines and adhesion molecules25. When infectious agents including foreign antigens and pathogens invade the skin, 
ectopic lymphoid tissue develops under the regulation of LT-α22. We found that Greenlandic Inuit with minor 
allele (CT) in the LT-α SNP rs2844484 had an increased risk of dermatitis, and the place of residence is significantly 
interacted with the association of LT-α SNP rs2844484 with dermatitis prevalence. In addition, the GTEx data 
also supported that individual with genotype CT of rs2844484 had a higher LT-α gene expression, relative to CC. 
Considering the regulatory role of LT-α cytokine in the immune defensive system, our data suggest that the LT-α 
gene variant affects the dermatitis prevalence, and this association is regulated by environmental factors.
Whole population 
(P value)
Full Inuit (P 
value) Meff
Significance 
Threshold
ORMDL3 rs12603332 & 
FEV1 in Greenland 0.058 0.014 1.0018 0.0253
ORMDL3 rs12603332 & FVC 
in Greenland 0.027 0.009 1.0018 0.0253
ORMDL3 rs4065275 & FEV1 
in Greenland 0.033 0.011 1.0018 0.0253
ORMDL3 rs4065275 & FVC 
in Greenland 0.023 0.005 1.0018 0.0253
ALOX5 rs892690 & Ever 
asthma in Greenland 0.025 0.029 2.686 0.0170
LT-α rs2844484 & Bronchitis 
in Denmark 0.002 0.044 1.8635 0.0253
LT-α rs909253 & Bronchitis 
in Denmark 0.090 0.019 1.8635 0.0253
LT-α rs1041981 & Bronchitis 
in Denmark 0.070 0.014 1.8635 0.0253
TNF-α rs1800629 & 
Bronchitis in Greenland 0.035 0.023 2.7127 0.0170
LT-α rs2844484 & Dermatitis 
in Greenland 0.035 0.025 1.8635 0.0253
Table 2. Correction for multiple comparisons in the significant associations identified. Meff : the effective 
number of SNPs tested within each gene.
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One limitation of our study is that the sample size is small after stratifying by genotype, particularly for SNP 
genotypes associated with low disease prevalence. Nevertheless, we identified several significant genetic effects as 
well as interactions with place of residence after testing in the sensitivity analysis and correcting for multiple tests. 
The relatively small sample size for the population study also reduces the statistical power and has potentially type 
2 errors (false negative). A larger sample size population with a similar genetic background is needed to validate 
or replicate our results. Consequently, the results should be interpreted with caution and we encourage further 
studies to confirm these findings.
Taken together, our data show that polymorphisms of ORMDL3 are related to lung function and affected by 
place of residence. Moreover, the candidate gene LT-α variants are significantly associated with either respiratory 
inflammation or allergic conditions. The effects of heterozygote on respiratory function and allergic traits are 
different in these associations. We argue that the protective effect of heterozygote is partly attributed to the natural 
consequence of adaptation, in which the fitness of the heterozygote is superior to either homozygote26. The asso-
ciations of the heterozygous genotypes with lung function and disease prevalence may also result from potential 
linkage of the SNP with other functional genetic variants or by a chance. The results should be interpreted with 
caution. Interestingly, these associations are environment dependent, indicating that environmental factors or life 
styles could modify genetic predisposition, and change the genetic effects on diseases.
Materials and Methods
Study populations. Two populations of Inuit were studied, the Inuit population residing in Qasigiannguit 
(North/West Greenland) and the first generation Inuit immigrants residing in Denmark. The mean length of 
residence in Denmark of the migrants was 23 years and they had lived 52% of their life in Denmark. The two Inuit 
populations were originally recruited as part of a larger study conducted by The Greenlandic Study Population 
Group27. All Inuit from both populations were born in Greenland. Inuit ethnicity was self-reported and ethnicity 
was documented by number of Inuit grandparents for each subject27.
Qasigiannguit is a small town, near the Arctic Circle, which is only accessible by boat during the short sum-
mer season. A high proportion of this population works outside as fishermen or hunters (60.4%) and consumes 
mainly traditional Greenlandic food (84.9%), such as marine mammals7.
The second Inuit population examined in this study are first generation immigrants residing in Copenhagen, 
the capital of Denmark. Copenhagen residents are considered to live in a predominantly ‘Western’ European cul-
ture and lifestyle. A low proportion of first generation immigrant Inuit in Denmark works as fishermen or hunters 
(0.4%), and rarely consumes traditional Greenlandic food (4.5%)7.
DNA was available of 625 Inuit from Qasigiannguit and 680 Inuit from Denmark of which 98.4% (n = 615) 
and 94.6% (n = 643) provided phenotypic data, respectively. The genotype and phenotype study was approved by 
the ethics committees of Bispebjerg University hospital, Denmark, and School of Paediatrics and Child Health, 
the University of Western Australia. All subjects gave informed consent prior to participation. All experiments 
were performed in accordance with relevant guidelines and regulations of Bispebjerg University hospital and 
School of Paediatrics and Child Health, the University of Western Australia.
Study design. This study investigated the environmental interaction between the individual genetic effects 
of the eight candidate genes (ADAM33, ALOX5, LT-α, LTC4S, NOS1, ORMDL3, TBXA2R, and TNF-α) on lung 
function and allergic conditions in Greenlandic and Danish Inuit. The cohorts are an unselected sample of adult 
participants, representative of their respective Inuit populations. The original data collection occurred during 
the years 1997–200127. This comprised of an interview, a questionnaire, clinical examinations, lung function 
studies and blood sample collection, and was performed by a team of seven investigators, consisting of trained 
staff from Denmark and staff from the local hospital with constant supervision by a senior investigator from the 
Greenlandic Population Study Group27.
Phenotypic characterization. Respiratory and allergic conditions (ever asthma, bronchitis, rhinitis, der-
matitis and atopy) were initially defined by the questionnaire27. Atopy was further determined using skin prick 
tests (SPTs) according to the European Academy of Allergy and Clinical Immunology (EAACI) guidelines. The 
allergens used for SPTs are commonly present in both Greenlandic and Danish environments, including birch, 
timothy grass, mugwort, animal dander (horse, dog, and cat), house dust mites (Dermatophagoides pteronyssinus 
and D. farina) and moulds (Alternaria alternate and Cladosporium herbarum). Atopy was recorded if a wheal size 
>3 mm to one of the allergens27.
Lung function parameter values were calculated from the completed capacities using a 7L wedge spirometer 
(Vitalograph Spiropharma, Copenhagen, Denmark), including reduced expiratory volume in one second (FEV1) 
and forced vital capacity (FVC) values28.
Selection of single nucleotide polymorphism (SNP). The SNP selection criteria are summarized in the 
flowchart of Fig. 4. Specifically, the search started with the Online Mendelian Inheritance in Man website (https://
omim.org) to obtain historical molecular genetics information and landmark papers about each candidate gene. 
Subsequently the Web of Knowledge database was employed to retrieve possible candidate gene SNPs from lit-
eratures published from 2004 to 2012. The Genetic Association Database (https://geneticassociationdb.nih.gov) 
was aligned to obtain other possible references using the “broad phenotype (disease)” category. NCBI dbSNP 
databases (http://www.ncbi.nlm.nih.gov/SNP/) and fastsnp (https://fastsnp.ibms.sinica.edu.tw/) were used as 
additional resources for analysing SNP details. The SNP information was collated into a database, e.g. the rs num-
ber, minor allele frequency (MAF), location within gene, associations with asthma and allergic diseases, ethnicity. 
Finally, the recorded SNPs from each candidate gene were ranked by P value, irrespective of positive or negative 
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associations. SNPs were selected based on significant association and with MAF > 0.15. We selected 19 SNPs for 
the study: ADAM33 (rs612709, rs528557, rs44707 and rs2787094); ALOX5 (rs4986832, rs892690 and rs2115819); 
LT-α (rs2844484, rs909253 and rs1041981); LTC4S (rs3776944 and rs730012); NOS1 (rs7977109); ORMDL3 
(rs12603332 and rs4065275/4378650); TBXA2R (rs4523); TNF-α (rs1799964, rs1800630 and rs1800629);
Genotyping. The genomic DNA was prepared from peripheral blood using standard methods27. The DNA 
was then genotyped for the selected SNPs using the Sequenom MassARRAY® system, with the iPLEX Gold 
Figure 4. Selection of single nucleotide polymorphisms (SNPs): Flow chart summarises the procedures for the 
selection of SNPs in the study. MAF: minor allele frequency.
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primer extension process and MALDI-TOF mass spectrometry analysis. All SNPs were successfully genotyped 
except LTC4S SNP rs3776944 that was thereafter not included in the analysis.
Genotype-tissue expression (GTEx) analysis. The five SNPs (ORMDL3 rs12603332 and rs4065275, 
LT-α rs909253, rs1041981 and rs2844484) were finally selected for further analysis. Utilizing the GTEx database 
(http://gtexportal.org/home, version V6)17, we investigated the association between genotypes and gene expres-
sion level in whole blood.
Statistical analysis. Assessments of Hardy Weinberg Equilibriums (HWE) were obtained via the Innate 
Immunity Programs for Genomic Applications collaboration website (https://regepi.bwh.harvard.edu/IIPGA2/
Bioinformatics/). The genotype frequencies were compared using Pearson χ2 test, further stratified by ethnicity. 
All genotype-phenotype association analyses were performed using a co-dominant model in which genotypes of 
SNPs were treated as categorical variables. Specifically, the associations were investigated using linear regression 
between SNPs and lung function and using logistic regression analyses between SNPs and disease prevalence. The 
regression analyses were adjusted for potential confounders e.g. gender, age, height, ethnicity, and smoking. The 
outcome variable was either the value of FEV1 and FVC or the frequency of respiratory/allergic phenotypes (Yes/
No), while the independent variables were SNP genotype and the potential confounders. A sensitivity analysis 
was further performed by analysing the genotype-phenotype associations in Inuit with full ethnicity (all four 
grandparents are Inuit).
The interactive effect of place of residence on genotype-phenotype associations was investigated by using 
the likelihood-ratio test after estimation in the regression models by pooling the two populations together. 
Both the unrestricted (with interaction) and the restricted (without interaction) models were fitted using the 
maximum-likelihood method, and subsequently these were compared to identify significant interactions. 
Differences with P < 0.05 were considered statistically significant.
All analyses mentioned above were conducted using the statistical package SPSS (version 20.0: SPSS Inc., 
Chicago, IL, USA) except for the likelihood-ratio tests for which STATA (StataCorp LP, College Station, TX, USA) 
was used.
In addition, a standard Bonferroni correction for multiple testing is considered too conservative without tak-
ing into account linkage disequilibrium between SNPs in the same gene. This can result in a significant overcor-
rection and subsequent loss of power. Inconsistencies that arise from population differences may be resolved by 
using a gene based approach rather than either a SNP-based or a haplotype-based approach29, 30. As the strong 
linkage disequilibrium was identified in the present study (Supplementary Fig. 1), we employed a gene-based 
approach and applied multiple comparison correction with respect to the number of SNPs in that gene. We 
used the method proposed by Li and Ji31 to calculate the number of independent components underlying the 
linkage disequilibrium structure of the set of SNPs, as implemented in Single Nucleotide Polymorphism Spectral 
Decomposition (SNPSpD)32.
Data Availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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